Payment overview · 2025
General Payments
$46.64
2 reported records · 1 companies
Healthcare provider profile · identity verified
Anwar Saeed, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CITRUS HEIGHTS, CA · NPI 1326073503
Verified facts
What the public records show
CMS Open Payments records show Anwar Saeed, MD received $46.64 in general payments during 2025 across 2 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $46.64 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $46.64 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $46.64 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1295 | 376 |
| Amlodipine Besylate | Amlodipine Besylate | 864 | 268 |
| Levothyroxine Sodium | Levothyroxine Sodium | 789 | 201 |
| Omeprazole | Omeprazole | 509 | 138 |
| Tamsulosin Hcl | Tamsulosin Hcl | 493 | 144 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 489 | 78 |
| Gabapentin | Gabapentin | 481 | 155 |
| Losartan Potassium | Losartan Potassium | 476 | 152 |
| Lisinopril | Lisinopril | 449 | 145 |
| Pantoprazole Sodium | Pantoprazole Sodium | 385 | 113 |
| Baclofen | Baclofen | 372 | 124 |
| Metformin Hcl | Metformin Hcl | 369 | 117 |
| Glipizide | Glipizide | 315 | 98 |
| Metoprolol Tartrate | Metoprolol Tartrate | 293 | 98 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 282 | 113 |
| Finasteride | Finasteride | 250 | 71 |
| Montelukast Sodium | Montelukast Sodium | 250 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 233 | 73 |
| Trazodone Hcl | Trazodone Hcl | 217 | 71 |
| Meloxicam | Meloxicam | 208 | 69 |
| Hydrochlorothiazide | Hydrochlorothiazide | 185 | 61 |
| Potassium Chloride | Potassium Chloride | 185 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 179 | 67 |
| Furosemide | Furosemide | 178 | 62 |
| Jardiance | Empagliflozin | 177 | 57 |
| Famotidine | Famotidine | 175 | 51 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 172 | 56 |
| Eliquis | Apixaban | 170 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 169 | 63 |
| Simvastatin | Simvastatin | 160 | 43 |
| Alendronate Sodium | Alendronate Sodium | 158 | 51 |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 59 |
| Mirtazapine | Mirtazapine | 148 | 44 |
| Naproxen | Naproxen | 141 | 65 |
| Alprazolam | Alprazolam | 137 | 32 |
| Allopurinol | Allopurinol | 132 | 40 |
| Sertraline Hcl | Sertraline Hcl | 132 | 51 |
| Tramadol Hcl | Tramadol Hcl | 128 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 123 | 34 |
| Atenolol | Atenolol | 118 | 31 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 118 | 39 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 118 | 19 |
| Carvedilol | Carvedilol | 115 | 33 |
| Donepezil Hcl | Donepezil Hcl | 109 | 31 |
| Lovastatin | Lovastatin | 109 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 35 |
| Ibuprofen | Ibuprofen | 107 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 102 | 35 |
| Buspirone Hcl | Buspirone Hcl | 98 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 97 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 91 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 89 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 36 |
| Januvia | Sitagliptin Phosphate | 87 | 24 |
| Clonidine Hcl | Clonidine Hcl | 84 | 25 |
| Felodipine Er | Felodipine | 82 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 78 | 26 |
| Propranolol Hcl | Propranolol Hcl | 77 | 23 |
| Lorazepam | Lorazepam | 72 | 23 |
| Bupropion Xl | Bupropion Hcl | 68 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 24 |
| Azithromycin | Azithromycin | 66 | 59 |
| Pregabalin | Pregabalin | 66 | 18 |
| Warfarin Sodium | Warfarin Sodium | 63 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 27 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | 22 |
| Memantine Hcl | Memantine Hcl | 60 | 18 |
| Valsartan | Valsartan | 60 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 18 |
| Ezetimibe | Ezetimibe | 58 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | 17 |
| Glimepiride | Glimepiride | 56 | 12 |
| Levetiracetam | Levetiracetam | 53 | 13 |
| Prednisone | Prednisone | 53 | 26 |
| Rybelsus | Semaglutide | 53 | 14 |
| Hydrocortisone | Hydrocortisone | 51 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 51 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 49 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Spironolactone | Spironolactone | 48 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | 18 |
| Xarelto | Rivaroxaban | 45 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 42 | 11 |
| Ozempic | Semaglutide | 41 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 40 | 34 |
| Trulicity | Dulaglutide | 40 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 39 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 39 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 35 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 38 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 38 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 14 |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Diazepam | Diazepam | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 35 | 16 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 35 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 22 |
| Benazepril Hcl | Benazepril Hcl | 33 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 30 | 11 |
| Synthroid | Levothyroxine Sodium | 30 | 12 |
| Acyclovir | Acyclovir | 29 | 12 |
| Mounjaro | Tirzepatide | 29 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 20 |
| Breyna | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Clonazepam | Clonazepam | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 12 |
| Temazepam | Temazepam | 28 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 28 | 12 |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 26 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | 12 |
| Fluconazole | Fluconazole | 24 | 16 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | 13 |
| Estradiol | Estradiol | 23 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Cephalexin | Cephalexin | 21 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | 11 |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 11 |
| Celecoxib | Celecoxib | 19 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 15 |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 16 |
| Olanzapine | Olanzapine | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 18 | suppressed |
| Niacin Er | Niacin | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Repatha Syringe | Evolocumab | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Victoza 3-Pak | Liraglutide | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 14 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Sumatriptan | Sumatriptan | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $46.64 · 2 records | Exact Sciences Corporation | The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error